Here is a list of stocks with an above 10% expected next quarter sales growth, and a 3% or higher return on equity. May these stocks be a good medium-term investment option?

1. Catalent, Inc.

22.5% sales growth and 10.21% return on equity

Catalent, Inc., together with its subsidiaries, provides delivery technologies and development solutions for drugs, biologics, and consumer and animal health products worldwide.

Catalent, Inc.’s sales growth this year is expected to be 20.4% and 9.8% for next year.

Year-on-year quarterly revenue growth grew by 27.2%, now sitting on 3.28B for the twelve trailing months.

Catalent, Inc.’s sales growth is a negative 0% for the current quarter and 22.5% for the next. The company’s growth estimates for the ongoing quarter and the next is 22.2% and 28%. The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 10.21%.

Volatility

Catalent, Inc.’s last day, last week, and last month’s average volatility was a negative 2.36%, a negative 0.41%, and a positive 0.40%, respectively.

Catalent, Inc.’s last day, last week, and last month’s high and low average amplitude percentage was 3.67%, 2.61%, and 2.78%, respectively.

Catalent, Inc.’s Stock Yearly Top and Bottom Value

Catalent, Inc.’s stock is valued at $102.88 at 10:22 EST, way under its 52-week high of $120.48 and way higher than its 52-week low of $31.04.

Catalent, Inc.’s Moving Average

Catalent, Inc.’s worth is above its 50-day moving average of $99.76 and way higher than its 200-day moving average of $88.65.

2. Abbott Laboratories

24.2% sales growth and 10.57% return on equity

Abbott Laboratories discovers, develops, manufactures, and sells health care products worldwide.

Abbott Laboratories’s sales growth this year is anticipated to be 6.2% and 14% for next year.

Year-on-year quarterly revenue growth grew by 9.6%, now sitting on 32.22B for the twelve trailing months.

Abbott Laboratories’s sales growth for the next quarter is 24.2%. The company’s growth estimates for the present quarter and the next is 42.1% and 60%. The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 10.57%.

Volatility

Abbott Laboratories’s last day, last week, and last month’s average volatility was a positive 0.84%, a negative 0.08%, and a positive 0.03%, respectively.

Abbott Laboratories’s last day, last week, and last month’s high and low average amplitude percentage was 1.46%, 2.03%, and 1.69%, respectively.

Abbott Laboratories’s Stock Yearly Top and Bottom Value

Abbott Laboratories’s stock is valued at $107.79 at 10:22 EST, below its 52-week high of $115.14 and way higher than its 52-week low of $61.61.

Abbott Laboratories’s Moving Average

Abbott Laboratories’s value is below its 50-day moving average of $108.86 and above its 200-day moving average of $103.41.

3. Tempur Sealy International, Inc.

8.5% sales growth and 63.13% return on equity

Tempur Sealy International, Inc., together with its subsidiaries, develops, manufactures, markets, and distributes bedding products in the United States, Canada, and internationally.

Tempur Sealy International, Inc.’s sales growth this year is expected to be 16.1% and 8.3% for next year.

Year-on-year quarterly revenue growth grew by 37.9%, now sitting on 3.49B for the twelve trailing months.

Tempur Sealy International, Inc.’s sales growth for the next quarter is 8.5%. The company’s growth estimates for the current quarter and the next is 50% and 21.2%. The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 63.13%.

Volatility

Tempur Sealy International, Inc.’s last day, last week, and last month’s average volatility was a positive 0.77%, a negative 0.22%, and a positive 0.42%, respectively.

Tempur Sealy International, Inc.’s last day, last week, and last month’s high and low average amplitude percentage was 2.06%, 3.18%, and 3.60%, respectively.

Tempur Sealy International, Inc.’s Stock Yearly Top and Bottom Value

Tempur Sealy International, Inc.’s stock is valued at $27.17 at 10:22 EST, under its 52-week high of $28.65 and way higher than its 52-week low of $5.50.

Tempur Sealy International, Inc.’s Moving Average

Tempur Sealy International, Inc.’s worth is above its 50-day moving average of $25.81 and way above its 200-day moving average of $22.09.

4. Duke Realty Corporation

9.7% sales growth and 4.35% return on equity

Duke Realty Corporation owns and operates approximately 156 million rentable square feet of industrial assets in 20 major logistics markets.

Duke Realty Corporation’s sales growth this year is expected to be 7.4% and 7.4% for next year.

Year-on-year quarterly revenue growth grew by 8.3%, now sitting on 968.52M for the twelve trailing months.

Duke Realty Corporation’s sales growth for the next quarter is 9.7%. The company’s growth estimates for the present quarter and the next is a negative 34.8% and 140%. The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 4.35%.

Volatility

Duke Realty Corporation’s last day, last week, and last month’s average volatility was 1.07%, 0.25%, and 0.12%, respectively.

Duke Realty Corporation’s last day, last week, and last month’s high and low average amplitude percentage was 1.76%, 1.83%, and 1.97%, respectively.

Duke Realty Corporation’s Stock Yearly Top and Bottom Value

Duke Realty Corporation’s stock is valued at $39.47 at 10:22 EST, under its 52-week high of $43.45 and way above its 52-week low of $25.19.

Duke Realty Corporation’s Moving Average

Duke Realty Corporation’s worth is above its 50-day moving average of $38.97 and higher than its 200-day moving average of $38.05.

5. Mackinac Financial Corporation

9.6% sales growth and 8.04% return on equity

Mackinac Financial Corporation operates as the bank holding company for mBank that provides commercial and retail banking products and services in the United States.

Mackinac Financial Corporation’s sales growth this year is expected to be 7.6% and a negative 3.7% for next year.

Year-on-year quarterly revenue growth grew by 4.1%, now sitting on 62.89M for the twelve trailing months.

Mackinac Financial Corporation’s sales growth for the next quarter is 9.6%. The company’s growth estimates for the ongoing quarter and the next is a negative 3.2% and negative 0%. The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 8.04%.

Volatility

Mackinac Financial Corporation’s last day, last week, and last month’s average volatility was a negative 1.80%, a negative 0.39%, and a positive 0.16%, respectively.

Mackinac Financial Corporation’s last day, last week, and last month’s high and low average amplitude percentage was 2.43%, 1.44%, and 3.26%, respectively.

Mackinac Financial Corporation’s Stock Yearly Top and Bottom Value

Mackinac Financial Corporation’s stock is valued at $12.76 at 10:22 EST, way below its 52-week high of $17.32 and way higher than its 52-week low of $6.52.

Mackinac Financial Corporation’s Moving Average

Mackinac Financial Corporation’s value is higher than its 50-day moving average of $12.73 and way above its 200-day moving average of $10.62.

LEAVE A REPLY

Please enter your comment!
Please enter your name here